Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Cann Group ( (AU:CAN) ).
Cann Group Limited has announced the conversion of Ms. Jenni Pilcher’s role as CEO & Managing Director from a fixed-term contract to a permanent position. This decision reflects the board’s satisfaction with her performance and aligns with the company’s best interests, ensuring stability in its leadership as it continues to focus on its strategic objectives.
More about Cann Group
Cann Group Limited is a company focused on enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines. With research facilities and corporate headquarters in Melbourne, the company operates a large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group offers a variety of dried flower and oil products, active pharmaceutical ingredients, and extracts to customers in Australia and globally. The company also owns Satipharm and its patent-protected capsule technology.
Average Trading Volume: 2,181,038
Technical Sentiment Signal: Sell
Current Market Cap: A$6.36M
For detailed information about CAN stock, go to TipRanks’ Stock Analysis page.